Data / Form D filings / Bond Biosciences, Inc.
Bond Biosciences, Inc.: Form D filing
Bond Biosciences, Inc., a health care company in Parkville, MO, filed a Form D with the SEC in 2026. The latest, on October 5, 2026, reports $7.6 million sold of a $15 million offering to 122 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 170 English Landing Drive Suite 201B, Parkville, MO, 64152
- Phone
- (650) 804-2139
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1824224
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 5 | Amendment | $15,000,000 | $7,614,879 | $7,385,121 | 122 | Apr 1 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Beckloff | Director | |
| Cory Berkland | Executive Officer, Director | |
| Timothy Opler | Director | |
| Michael A. Riley | Executive Officer, Director | |
| Jay Shepard | Director |
Every Form D from the week of Oct 5 · All recent filings in Missouri · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Bond Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.